Pacira Biosciences Inc
SWB:82P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacira Biosciences Inc
SWB:82P
|
US |
|
N
|
Nordic American Tanker Ltd
LSE:0UC0
|
BM |
|
I
|
Isabella Bank Corp
NASDAQ:ISBA
|
US |
|
W
|
WEC Energy Group Inc
DUS:WIC
|
US |
|
V
|
ViacomCBS Inc
LSE:0A65
|
US |
|
S
|
Summit Materials Inc
F:7SU
|
US |
|
A
|
Assetwise PCL
SET:ASW
|
TH |
|
A
|
Alibaba Group Holding Ltd
OTC:BABAF
|
CN |
|
D
|
D'Ieteren Group NV
SWB:DJDA
|
BE |
Wall St Price Targets
82P Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for 82P is 25.36 EUR with a low forecast of 20.01 EUR and a high forecast of 34.38 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 82P's stock price target?
Price Target
25.36
EUR
According to Wall Street analysts, the average 1-year price target for 82P is 25.36 EUR with a low forecast of 20.01 EUR and a high forecast of 34.38 EUR.
What is the Revenue forecast for Pacira Biosciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Pacira Biosciences Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 41%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Pacira Biosciences Inc?
Projected CAGR
110%
The compound annual growth rate for Operating Income over the next 3 years is 110%.
What is the Pre-Tax Income forecast for Pacira Biosciences Inc?
Projected CAGR
163%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 163%.
What is the Net Income forecast for Pacira Biosciences Inc?
Projected CAGR
224%
The compound annual growth rate for Net Income over the next 3 years is 224%.
